相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase III Study of the Value of Thalidomide Added to Melphalan Plus Prednisone in Elderly Patients With Newly Diagnosed Multiple Myeloma: The HOVON 49 Study
Pierre Wijermans et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Skeletal Plasmacytoma: Progression of disease and impact of local treatment; an analysis of SEER database
Muhammad Umar Jawad et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
Jesus F. San Miguel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial
Thierry Facon et al.
LANCET (2007)
Immunoglobulin free light chains and solitary plasmacytoma of bone
David Dingli et al.
BLOOD (2006)
Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control
L Tournier-Rangeard et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Outcomes and patterns of failure in solitary plasmacytoma: A multicenter rare cancer network study of 258 patients
M Ozsahin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Solitary plasmacytoma of bone and soft tissues
WM Mendenhall et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2003)
Extramedullary plasmacytoma: Clinical and histopathologic study
P Strojan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone
RB Wilder et al.
CANCER (2002)
Solitary plasmacytoma treated with radiotherapy: Impact of tumor size on outcome
RW Tsang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
分享论文
